myrcene
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2020 (NCT04451863)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
C=CC(=C)CCC=C(C)C- Mol. weight
- 136.24 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL455491 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05432284 | Phase 1 | May 31, 2023 | Johns Hopkins University, National Institute on Drug Abuse (NIDA) |
| NCT04451863 | Phase 1 | Nov 30, 2020 | National Center for Complementary and Integrative Health (NCCIH), University of California, Los Angeles |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| National Center for Complementary and Integrative Health (NCCIH) | Government | 1 | 0 | 1 | 2020 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2023 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2020 |
4 organizations
Page 1 / 1